Inge Winter-van Rossum

805 total citations
16 papers, 210 citations indexed

About

Inge Winter-van Rossum is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Cognitive Neuroscience. According to data from OpenAlex, Inge Winter-van Rossum has authored 16 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 4 papers in Biological Psychiatry and 4 papers in Cognitive Neuroscience. Recurrent topics in Inge Winter-van Rossum's work include Schizophrenia research and treatment (13 papers), Bipolar Disorder and Treatment (5 papers) and Tryptophan and brain disorders (4 papers). Inge Winter-van Rossum is often cited by papers focused on Schizophrenia research and treatment (13 papers), Bipolar Disorder and Treatment (5 papers) and Tryptophan and brain disorders (4 papers). Inge Winter-van Rossum collaborates with scholars based in Netherlands, Germany and Spain. Inge Winter-van Rossum's co-authors include René S. Kahn, Celso Arango, Iris E. Sommer, Philip McGuire, Birte Glenthøj, Marion Leboyer, Dan Rujescu, Shitij Kapur, Andreas Meyer‐Lindenberg and Shôn Lewis and has published in prestigious journals such as PLoS ONE, Neuroscience & Biobehavioral Reviews and Schizophrenia Bulletin.

In The Last Decade

Inge Winter-van Rossum

15 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inge Winter-van Rossum Netherlands 8 124 65 43 32 26 16 210
Alejandro Ballesteros Spain 10 174 1.4× 56 0.9× 100 2.3× 33 1.0× 26 1.0× 26 283
María Juncal‐Ruíz Spain 11 196 1.6× 67 1.0× 24 0.6× 16 0.5× 48 1.8× 22 288
Chengcheng Pu China 9 135 1.1× 36 0.6× 118 2.7× 42 1.3× 31 1.2× 32 311
Dorte Nordholm Denmark 10 153 1.2× 53 0.8× 87 2.0× 38 1.2× 56 2.2× 16 277
Ingrid Melle Norway 3 198 1.6× 34 0.5× 58 1.3× 27 0.8× 49 1.9× 5 257
Giovanni Amodeo Italy 7 77 0.6× 42 0.6× 18 0.4× 28 0.9× 33 1.3× 15 172
Patricia Correa‐Ghisays Spain 11 141 1.1× 52 0.8× 38 0.9× 34 1.1× 32 1.2× 22 213
Alba Toll Spain 8 128 1.0× 50 0.8× 36 0.8× 24 0.8× 70 2.7× 29 246
Isabel Maurus Germany 9 127 1.0× 26 0.4× 41 1.0× 19 0.6× 36 1.4× 23 233
Bruno Bertolucci Ortiz Brazil 10 196 1.6× 81 1.2× 60 1.4× 31 1.0× 57 2.2× 19 315

Countries citing papers authored by Inge Winter-van Rossum

Since Specialization
Citations

This map shows the geographic impact of Inge Winter-van Rossum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Winter-van Rossum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Winter-van Rossum more than expected).

Fields of papers citing papers by Inge Winter-van Rossum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Winter-van Rossum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Winter-van Rossum. The network helps show where Inge Winter-van Rossum may publish in the future.

Co-authorship network of co-authors of Inge Winter-van Rossum

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Winter-van Rossum. A scholar is included among the top collaborators of Inge Winter-van Rossum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Winter-van Rossum. Inge Winter-van Rossum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Penninx, Brenda W.J.H., Celso Arango, Nic J.A. van der Wee, et al.. (2024). The aperiodic exponent of neural activity varies with vigilance state in mice and men. PLoS ONE. 19(8). e0301406–e0301406. 2 indexed citations
2.
Luykx, Jurjen J., Inge Winter-van Rossum, Patrick Waters, et al.. (2024). Clinical symptoms and psychosocial functioning in patients with schizophrenia spectrum disorders testing seropositive for anti-NMDAR antibodies: a case–control comparison with patients testing negative. The Lancet Psychiatry. 11(10). 828–838. 4 indexed citations
3.
Worker, Amanda, Andrew J. Lawrence, Seyed Mostafa Kia, et al.. (2023). Extreme deviations from the normative model reveal cortical heterogeneity and associations with negative symptom severity in first-episode psychosis from the OPTiMiSE and GAP studies. Translational Psychiatry. 13(1). 373–373. 8 indexed citations
4.
Kia, Seyed Mostafa, et al.. (2023). Revealing the impact of psychiatric comorbidities on treatment outcome in early psychosis using counterfactual model explanation. Frontiers in Psychiatry. 14. 1237490–1237490. 1 indexed citations
5.
Rossum, Inge Winter-van, et al.. (2023). Generalizability of the Results of Efficacy Trials in First-Episode Schizophrenia. The Journal of Clinical Psychiatry. 84(3). 1 indexed citations
6.
Föcking, Melanie, David Mongan, Meike Heurich, et al.. (2023). Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical Trial. Schizophrenia Bulletin. 49(4). 893–902. 9 indexed citations
7.
Kas, Martien J., Niels Jongs, Maarten Mennes, et al.. (2023). Digital behavioural signatures reveal trans-diagnostic clusters of Schizophrenia and Alzheimer's disease patients. European Neuropsychopharmacology. 78. 3–12. 7 indexed citations
8.
Levi, Linda, Inge Winter-van Rossum, Michael L. Davidson, et al.. (2023). Cannabis Use and Symptomatic Relapse in First Episode Schizophrenia: Trigger or Consequence? Data From the OPTIMISE Study. Schizophrenia Bulletin. 49(4). 903–913. 6 indexed citations
9.
Gangadin, Shiral S., Inge Winter-van Rossum, Zimbo S. R. M. Boudewijns, et al.. (2021). The effect of prednisolone on symptom severity in schizophrenia: A placebo-controlled, randomized controlled trial. Schizophrenia Research. 230. 79–86. 11 indexed citations
10.
Levi, Linda, Inge Winter-van Rossum, Stephan Heres, et al.. (2020). Duration of untreated psychosis and response to treatment: an analysis of response in the OPTiMiSE cohort. European Neuropsychopharmacology. 32. 131–135. 15 indexed citations
11.
Baal, G. Caroline M. van, Celso Arango, Covadonga M. Díaz‐Caneja, et al.. (2020). Hostility and aggressive behaviour in first episode psychosis: Results from the OPTiMiSE trial. Schizophrenia Research. 223. 271–278. 11 indexed citations
12.
Pandit, Rahul, Daniela Cianci, Inge Winter-van Rossum, et al.. (2019). Phenotypic factors associated with amisulpride‐induced weight gain in first‐episode psychosis patients (from the OPTiMiSE cohort). Acta Psychiatrica Scandinavica. 140(3). 283–290. 4 indexed citations
13.
Bilderbeck, Amy C., Brenda W.J.H. Penninx, Celso Arango, et al.. (2018). Overview of the clinical implementation of a study exploring social withdrawal in patients with schizophrenia and Alzheimer’s disease. Neuroscience & Biobehavioral Reviews. 97. 87–93. 30 indexed citations
14.
Leucht, Stefan, Inge Winter-van Rossum, Stephan Heres, et al.. (2016). The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching Antipsychotics. FOCUS The Journal of Lifelong Learning in Psychiatry. 14(3). 378–386.
15.
Fond, Guillaume, Marc-Antoine d’Albis, Stéphane Jamain, et al.. (2015). The Promise of Biological Markers for Treatment Response in First-Episode Psychosis: A Systematic Review. Schizophrenia Bulletin. 41(3). 559–573. 65 indexed citations
16.
Leucht, Stefan, Inge Winter-van Rossum, Stephan Heres, et al.. (2015). The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for its Methodology and a Review of the Effectiveness of Switching Antipsychotics. Schizophrenia Bulletin. 41(3). 549–558. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alejandro Ballesteros Breakdown of academic impact, for papers by María Juncal‐Ruíz Breakdown of academic impact, for papers by Chengcheng Pu Breakdown of academic impact, for papers by Dorte Nordholm Breakdown of academic impact, for papers by Ingrid Melle Breakdown of academic impact, for papers by Giovanni Amodeo Breakdown of academic impact, for papers by Patricia Correa‐Ghisays Breakdown of academic impact, for papers by Alba Toll Breakdown of academic impact, for papers by Isabel Maurus Breakdown of academic impact, for papers by Bruno Bertolucci Ortiz
Rankless by CCL
2026